Literature DB >> 24875449

Class A scavenger receptor deficiency augments angiotensin II-induced vascular remodeling.

Lingling Qian1, Xiaoyu Li2, Ru Fang2, Zhuoyun Wang3, Yiming Xu2, Hanwen Zhang2, Hui Bai2, Qing Yang2, Xudong Zhu2, Jingjing Ben3, Yong Xu2, Qi Chen4.   

Abstract

Class A scavenger receptor (SR-A) is a multifunctional molecule that participates in macrophage-mediated inflammation. Here we evaluated the role of SR-A in angiotensin II (Ang II)-induced hypertensive vascular remodeling. Chronic infusion of Ang II leads to an increased systolic blood pressure both in SR-A knockout (SR-A(-/-)) and wild type (SR-A(+/+)) mice with no significant difference between these two groups. SR-A(-/-) hypertensive mice, however, exhibited a marked augmentation of arterial wall thickening and vascular cell proliferation compared with SR-A(+/+) hypertensive mice. M1 macrophage markers were increased whereas M2 macrophage markers were decreased in vascular tissues of SR-A(-/-) mice. Co-culture experiments revealed that more pro-inflammatory cytokines like TNF-α were produced by SR-A(-/-) peritoneal macrophages leading to a stronger proliferation of primary vascular smooth muscle cells in vitro. In addition, SR-A(-/-) macrophages were more prone to lipopolysaccharide-induced M1 differentiation while resisting interleukin-4-induced M2 differentiation. Importantly, transplantation of SR-A(-/-) bone marrow into SR-A(+/+) mice significantly augmented Ang II-induced vascular remodeling. These results show that SR-A is critical for Ang II-induced vascular remodeling by regulating macrophage polarization. Therefore, SR-A may be a useful therapeutic target for the intervention of hypertensive vascular remodeling.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BAY 11-708 (PubChem CID: 24891842); Hypertension; Inflammation; Macrophage polarization; Pentoxifylline (PubChem CID: 4740); SR-A; Teriflunomide (PubChem CID: 4651473); Vascular remodeling

Mesh:

Substances:

Year:  2014        PMID: 24875449     DOI: 10.1016/j.bcp.2014.05.015

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  Genetic variants of the class A scavenger receptor gene are associated with essential hypertension in Chinese.

Authors:  Min Zhang; Zhijun Han; Zihe Yan; Qichen Cui; Yuhai Jiang; Mingzhu Gao; Wei Yu; Jun Hua; Hongyu Huang
Journal:  J Thorac Dis       Date:  2015-11       Impact factor: 2.895

Review 2.  Age-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries.

Authors:  Mingyi Wang; Ajay M Shah
Journal:  J Mol Cell Cardiol       Date:  2015-02-07       Impact factor: 5.000

Review 3.  Efferocytosis and Outside-In Signaling by Cardiac Phagocytes. Links to Repair, Cellular Programming, and Intercellular Crosstalk in Heart.

Authors:  Matthew DeBerge; Shuang Zhang; Kristofor Glinton; Luba Grigoryeva; Islam Hussein; Esther Vorovich; Karen Ho; Xunrong Luo; Edward B Thorp
Journal:  Front Immunol       Date:  2017-11-01       Impact factor: 7.561

Review 4.  M2 Macrophages as a Potential Target for Antiatherosclerosis Treatment.

Authors:  Ying Bi; Jixiang Chen; Feng Hu; Jing Liu; Man Li; Lei Zhao
Journal:  Neural Plast       Date:  2019-02-21       Impact factor: 3.599

5.  CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis.

Authors:  Gregor Olmes; Maike Büttner-Herold; Fulvia Ferrazzi; Luitpold Distel; Kerstin Amann; Christoph Daniel
Journal:  Arthritis Res Ther       Date:  2016-04-18       Impact factor: 5.156

6.  Macrophage MSR1 promotes BMSC osteogenic differentiation and M2-like polarization by activating PI3K/AKT/GSK3β/β-catenin pathway.

Authors:  Shu-Jie Zhao; Fan-Qi Kong; Jian Jie; Qing Li; Hao Liu; An-Di Xu; Ya-Qing Yang; Bin Jiang; Dong-Dong Wang; Zhong-Qiu Zhou; Peng-Yu Tang; Jian Chen; Qian Wang; Zheng Zhou; Qi Chen; Guo-Yong Yin; Han-Wen Zhang; Jin Fan
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.